Schroder Investment Management Group Purchases 2,673 Shares of LifePoint Health Inc (LPNT)

Schroder Investment Management Group boosted its position in LifePoint Health Inc (NASDAQ:LPNT) by 2.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 119,644 shares of the company’s stock after acquiring an additional 2,673 shares during the period. Schroder Investment Management Group owned 0.30% of LifePoint Health worth $6,999,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in LPNT. LS Investment Advisors LLC boosted its holdings in LifePoint Health by 43.7% in the second quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock worth $120,000 after acquiring an additional 543 shares in the last quarter. Aperio Group LLC lifted its holdings in shares of LifePoint Health by 26.9% in the second quarter. Aperio Group LLC now owns 22,456 shares of the company’s stock valued at $1,508,000 after purchasing an additional 4,767 shares in the last quarter. US Bancorp DE lifted its holdings in shares of LifePoint Health by 0.8% in the second quarter. US Bancorp DE now owns 1,947 shares of the company’s stock valued at $130,000 after purchasing an additional 16 shares in the last quarter. Great West Life Assurance Co. Can lifted its holdings in shares of LifePoint Health by 3.3% in the second quarter. Great West Life Assurance Co. Can now owns 24,124 shares of the company’s stock valued at $1,619,000 after purchasing an additional 775 shares in the last quarter. Finally, Texas Permanent School Fund lifted its holdings in shares of LifePoint Health by 1.9% in the second quarter. Texas Permanent School Fund now owns 29,471 shares of the company’s stock valued at $1,979,000 after purchasing an additional 551 shares in the last quarter. Institutional investors and hedge funds own 99.18% of the company’s stock.

Shares of LifePoint Health Inc (NASDAQ:LPNT) opened at $46.75 on Friday. The company has a current ratio of 1.85, a quick ratio of 1.65 and a debt-to-equity ratio of 1.24. The company has a market capitalization of $1,828.89, a P/E ratio of 11.84, a P/E/G ratio of 1.21 and a beta of 0.67. LifePoint Health Inc has a 52-week low of $42.50 and a 52-week high of $70.95.

LifePoint Health (NASDAQ:LPNT) last issued its quarterly earnings results on Friday, October 27th. The company reported $0.80 EPS for the quarter, missing the Zacks’ consensus estimate of $0.95 by ($0.15). The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.60 billion. LifePoint Health had a net margin of 2.45% and a return on equity of 7.01%. The business’s revenue was down .7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.94 earnings per share. research analysts anticipate that LifePoint Health Inc will post 3.64 EPS for the current fiscal year.

LifePoint Health announced that its Board of Directors has approved a share buyback plan on Friday, October 27th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its stock is undervalued.

A number of research firms have recently weighed in on LPNT. William Blair restated an “outperform” rating on shares of LifePoint Health in a report on Tuesday, November 21st. Credit Suisse Group began coverage on LifePoint Health in a report on Thursday, November 2nd. They issued a “neutral” rating and a $54.00 target price on the stock. Zacks Investment Research lowered LifePoint Health from a “hold” rating to a “sell” rating in a report on Tuesday, October 31st. SunTrust Banks set a $54.00 target price on LifePoint Health and gave the company a “hold” rating in a report on Tuesday, October 31st. Finally, Leerink Swann restated an “outperform” rating and issued a $58.00 target price (down previously from $74.00) on shares of LifePoint Health in a report on Tuesday, October 31st. They noted that the move was a valuation call. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and five have given a buy rating to the company’s stock. LifePoint Health presently has a consensus rating of “Hold” and an average price target of $60.23.

In related news, Director Marguerite Kondracke sold 3,907 shares of the stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $44.73, for a total transaction of $174,760.11. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 8.76% of the company’s stock.

WARNING: This piece of content was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of international trademark and copyright laws. The legal version of this piece of content can be accessed at https://stocknewstimes.com/2017/12/10/schroder-investment-management-group-purchases-2673-shares-of-lifepoint-health-inc-lpnt.html.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Institutional Ownership by Quarter for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply